What are the most important changes in the 2019 ESC/EAS Dyslipidemia Guidelines?
In the Cardiovascular Scene Investigation (CSI) series, investigators from Utrecht report at the ESC congress, from the perspective of young investigators. They put a question to researchers about presented study results.
Prof. François Mach, MD is head of the Cardiology Department at the Geneva University Hospital in Switzerland. He was co-chair of the Task Force for the 2019 ESC/EAS Dyslipidemia Guidelines.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: